<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03552731</url>
  </required_header>
  <id_info>
    <org_study_id>RUMCPSY-ONC</org_study_id>
    <nct_id>NCT03552731</nct_id>
  </id_info>
  <brief_title>Evaluation of Depression and Anxiety in Chemotherapy Patients</brief_title>
  <official_title>Evaluation of Depression and Anxiety in Chemotherapy Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Richmond University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Richmond University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the existence and severity of depression and anxiety in patients
      undergoing chemotherapy at RUMC. Patients currently undergoing initial chemotherapy cycle
      will be compared to patients undergoing a subsequent chemotherapy cycle. Data will then be
      collected using standardized depression and anxiety scales to assess if these comorbidities
      exist and to what severity level. Data already collected for depression and anxiety in
      patients with chronic, but not cancer, illness will be used as a control.

      The participants will be screened for signs of psychological distress using three self
      administered questionnaires: the Generalized Anxiety Disorder 7 item Scale (GAD7) and Patient
      Health Questionnaire (PHQ9). Demographic information about the participants, including
      medical and psychiatric history, will also be gathered from their medical records.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to see how common Anxiety, Depression and distress are in people
      who are undergoing treatment for cancer. We want to understand how common these issues are in
      order to better screen for, and treat people suffering from them. Past studies have shown
      that people with anxiety or depression and cancer have worse outcomes, and a study evaluating
      how common these issues are has not been done. Patients presenting for chemotherapy will be
      identified and approached for participation by members of the research team. The purpose and
      design of the study will be explained. After informed consent is obtained, the surveys will
      be administered by the study team. Completing surveys will take 20 minuets. Relevant
      demographic information will be collected from the patients EMR. Recruitment will extend over
      one year period. Those determined to be suffering from anxiety or depression will be given
      the option of psychiatric follow up or intervention.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">December 20, 2017</start_date>
  <completion_date type="Anticipated">December 20, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Generalized Anxiety Disorder Screener (GAD-7)</measure>
    <time_frame>Two years</time_frame>
    <description>Generalized Anxiety Disorder 7 (GAD-7) is a self-reported questionnaire for screening and severity measuring of generalized anxiety disorder (GAD). GAD-7 consists total score for the seven items ranges from 0 to 21. Scores of 5, 10, and 15 represent cut points for mild, moderate, and severe anxiety, respectively. Using the threshold score of 10, the GAD-7 has a sensitivity of 89% and a specificity of 82% for generalized anxiety disorder.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Heath Questionnaire-9 (PHQ-9)</measure>
    <time_frame>Two years</time_frame>
    <description>The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression: The PHQ-9 incorporates DSM-IV depression diagnostic criteria with other leading major depressive symptoms into a brief self-report tool.Depression Severity: 0- none, 1-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. Validity has been assessed against an independent structured mental health professional (MHP) interview. PHQ-9 score â‰¥10 had a sensitivity of 88% and a specificity of 88% for major depression.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Demographic Information</measure>
    <time_frame>Two years</time_frame>
    <description>To gather demographic information with a Demographic Survey</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Oncology Problem</condition>
  <arm_group>
    <arm_group_label>Subsequent</arm_group_label>
    <description>Patients who have been receiving chemotherapy more than once. A intervention survey will be administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Time</arm_group_label>
    <description>Patients who have been receiving chemotherapy first time. A intervention survey will be administered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Surveys</intervention_name>
    <description>GAD 7 Survey and PHQ 9 Interventional survey will be administered in both groups.</description>
    <arm_group_label>First Time</arm_group_label>
    <arm_group_label>Subsequent</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults receiving chemotherapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:1)Patients (greater than equal to) 18 years of age 2)Patients with a
        confirmed diagnosis of a solid tumor or hematologic cancer 3)Patients who are able to
        understand the informed consent and read the selfadministered metrics. 4)Patients
        undergoing chemotherapy.

        -

        Exclusion Criteria:

          -  Patients unable to give informed consent.

          -  Patients with a previous diagnosis of anxiety or depression prior to chemotherapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Dennis Bloomfield, MD</last_name>
    <role>Study Director</role>
    <affiliation>Richmond University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dennis Bloomfield</last_name>
    <phone>718-818-2707</phone>
    <email>dbloomfield@rumcsi.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anita Trupiano</last_name>
    <phone>718-818-2707</phone>
    <email>atrupiano@rumcsi.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Richmond University Medical Center</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10310</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis Bloomfield, MD</last_name>
      <phone>718-818-2707</phone>
    </contact>
    <contact_backup>
      <last_name>Anita Trupiano, MS</last_name>
      <phone>718-818-2707</phone>
    </contact_backup>
    <investigator>
      <last_name>Dennis Bloomfield, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joel Idowu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Khushbu Shah, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Safwa Zafar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Asad Shaikh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Himanga Kalinga, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anita Trupiano, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adnan Nasir, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Richmond University Medical Center</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10310</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis Bloomfield, MD</last_name>
      <phone>718-818-2707</phone>
    </contact>
    <contact_backup>
      <last_name>Anita Trupiano, MS</last_name>
      <phone>718-818-2707</phone>
    </contact_backup>
    <investigator>
      <last_name>Dennis Bloomfield, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joel Idowu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Khushbu Shah, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Safwa Zafar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Asad Shaikh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Himanga Kalinga, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anita Trupiano, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Richmond University Medical Center</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10310</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita M Trupiano, MS</last_name>
      <phone>718-818-2707</phone>
      <email>atrupiano@rumcsi.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 7, 2018</study_first_submitted>
  <study_first_submitted_qc>June 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2018</study_first_posted>
  <last_update_submitted>June 13, 2018</last_update_submitted>
  <last_update_submitted_qc>June 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

